- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 260
Satt offices drive Team-to-Market
French regional TTOs Satt Conectus, Satt Nord and Satt Sayens hope to source skilled business leaders and management for their pipeline of deep tech spinouts.
Jun 13, 2019UCSD banks EvoNexus partnership
UCSD students and alumni will have access to a fintech incubator run by EvoNexus, Royal Bank of Canada and Franklin Templeton.
Jun 13, 2019Audio Analytic passes $12m audition
Cambridge Innovation Capital backed sound recognition technology developer Audio Analytic's $12m series B round, having previously also supported a $5.5m series A in 2017.
Jun 13, 2019Owens anticipates Wond'ry job
David Owens will succeed Robert Grajewski as executive director of Vanderbilt University’s Wond’ry innovation and entrepreneurship center on July 1.
Jun 13, 2019Allied Minds’ board comes under siege
Crystal Amber could move to replace the board with a single appointee to drive through divestments, having already forced the resignation of former CEO Jill Smith.
Jun 13, 2019Merck tackles $773m Tilos acquisition
Merck & Co will pay up to $773m to acquire biopharmaceutical developer Tilos Therapeutics, based on research at Harvard Medical School and Brigham & Women’s Hospital.
Jun 12, 2019Sense Photonics grasps $26m series A
Lidar technology developer Sense Photonics has emerged from stealth with $26m in series A funding from investors co-led by the UC-backed Congruent Ventures.
Jun 12, 2019Salesforce processes $15.7bn Tableau acquisition
Stanford spinout Tableau Software has agreed to a $15.7bn all-stock acquisition by Salesforce, six years after completing a $254m initial public offering on the New York Stock Exchange.
Jun 12, 2019Read joins Uniseed
Leanna Read, appointed South Australia’s chief scientist in 2014, has joined Uniseed as an independent board member.
Jun 11, 2019Artizan masters series A
Artizan, a Yale University spinout focused on intestinal microbiota targets potentially responsible for inflammatory bowel disease, has been backed by investors including Brii Biosciences, bringing its total funding to $12m.
Jun 11, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


